Tomasz Janus

Tomasz Janus

Auto-generated profile, based on publicly available information

Tomasz Janus

Department of Forensic and Clinical Toxicology, Pomeranian Medical University in Szczecin, Szczecin, Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2020 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
KBKatarzyna Brzeźniakiewicz-Janus
Katarzyna Brzeźniakiewicz-Janus
JRJoanna Rupa-Matysek
Joanna Rupa-Matysek
Andrzej TukiendorfAndrzej Tukiendorf
Andrzej Tukiendorf
TJTomasz Janus
Tomasz Janus
MFMirosław Franków
Mirosław Franków
LGLidia Gil
Lidia Gil
This study presents the statistical results of patients who had been recently discharged from hospital within one month after their treatment in the emergency department (ED). Using routine (14,881) MCV and RDW measurements and statistical tools, we could predict acute mortality in these patients (N = 1158), adjusted for age. It is likely that an increase in the MCV and RDW parameters may correlate in some of our older patients with a poor prognosis with an increased level of circulating IGF–I, which affects red blood cell parameters. The research presents the prognostic statistics of the analyzed clinical factors as well as speculates on the potential correlation of these parameters with the regenerative potential of stem-cell compartment. Analysis shows that both MCV and RDW are statistically significant (Area Under Curve [AUC], lower CI 95% >50%) predictors of acute mortality in ED patients. The classification of patients based on their MCV threshold (= 92.2 units) indicates a proper clinical prognosis in nearly 6 of 10 subjects (AUC >58%), whereas taking into account RDW (=13.8%) indicates a proper clinical prognosis in no more than 7 of 10 individuals. The report concludes that by employing strongly fitting (95%) quadratic modeling of the ORs against the biomarkers studied, one can notice a similar relationship between MCV and RDW as diagnostic tools to predict regenerative potential and clinical outcomes in older patients. Although RDW alone had a 10% higher diagnostic value in terms of predicting early death in the emergency department in patients that were admitted to the ED and subsequently hospitalized, also taking the MCV measurement improved accuracy in predicting clinical outcomes by 2.5% compared to RDW alone.

3 September 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
UAUrszula Adamiak-Giera
Urszula Adamiak-Giera
WJWojciech Jawień
Wojciech Jawień
APAnna Pierzchlinska
Anna Pierzchlinska
MBMonika Białecka
Monika Białecka
JKJan Kobierski
Jan Kobierski
BGBarbara Gawrońska-Szklarz
Barbara Gawrońska-Szklarz
Parkinson’s disease (PD) is a progressive, neurodegenerative disorder primarily affecting dopaminergic neuronal systems, with impaired motor function as a consequence. The most effective treatment for PD remains the administration of oral levodopa (LD). Long-term LD treatment is frequently associated with motor fluctuations and dyskinesias, which exert a serious impact on a patient’s quality of life. The aim of our study was to determine the pharmacokinetics of LD: used as monotherapy or in combination with ropinirole, in patients with advanced PD. Furthermore, an effect of ropinirole on the pharmacokinetics of 3-OMD (a major LD metabolite) was assessed. We also investigated the correlation between the pharmacokinetic parameters of LD and 3-OMD and the occurrence of motor complications. Twenty-seven patients with idiopathic PD participated in the study. Thirteen patients received both LD and ropinirole, and fourteen administered LD monotherapy. Among 27 patients, twelve experienced fluctuations and/or dyskinesias, whereas fifteen were free of motor complications. Inter- and intra-individual variation in the LD and 3-OMD concentrations were observed. There were no significant differences in the LD and 3-OMD concentrations between the patients treated with a combined therapy of LD and ropinirole, and LD monotherapy. There were no significant differences in the LD concentrations in patients with and without motor complications; however, plasma 3-OMD levels were significantly higher in patients with motor complications. A linear one-compartment pharmacokinetic model with the first-order absorption was adopted for LD and 3-OMD. Only mean exit (residence) time for 3-OMD was significantly shorter in patients treated with ropinirole. Lag time, V/F, CL/F and tmax of LD had significantly lower values in patients with motor complications. On the other hand, AUC were significantly higher in these patients, both for LD and 3-OMD. 3-OMD Cmax was significantly higher in patients with motor complications as well. Our results showed that ropinirole does not influence LD or 3-OMD concentrations. Higher 3-OMD levels play a role in inducing motor complications during long-term levodopa therapy.

16 July 2020 in Disease Markers
Verified
Journal Article
Open access
PDF file
KBKatarzyna Brzeźniakiewicz-Janus
Katarzyna Brzeźniakiewicz-Janus
MLMarcus Daniel Lancé
Marcus Daniel Lancé
Andrzej TukiendorfAndrzej Tukiendorf
Andrzej Tukiendorf
TJTomasz Janus
Tomasz Janus
MFMirosław Franków
Mirosław Franków
LGLidia Gil
Lidia Gil
Background.Complete blood count (CBC), red cell distribution width (RDW), mean platelet volume (MPV), mean corpuscular volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), or platelet (PLT) count are referred as predictors of adverse clinical outcomes in patients. The aim of the research was to identify potential factors of acute mortality in Polish emergency department (ED) patients by using selected hematological biomarkers and routine statistical tools. Methods. The study presents statistical results on patients who were recently discharged from inpatient facilities within one month prior to the index ED visit. In total, the analysis comprised 14,881 patients with the first RDW, MPV, MCV, MCH, MCHC, or PLT biomarkers' measurements recorded in the emergency department within the years 2016-2019 with a subsequent one month of all-cause mortality observation. The patients were classified with the codes of the International Statistical Classification of Diseases and Related Health Problems after 10(th) Revision (ICD10). Results. Based on the analysis of RDW, MPV, MCV, MCH, MCHC, and PLT on acute deaths in patients, we establish strong linear and quadratic relationships between the risk factors under study and the clinical response (P95 fL), whereas MCH, MCHC, and PLT have no impact on the excess acute mortality in ED patients.

29 December 2022 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
TJTomasz Janus
Tomasz Janus
UKUrszula Korbal
Urszula Korbal
MŻMaciej Żukowski
Maciej Żukowski
ALAgnieszka Lewosiuk
Agnieszka Lewosiuk
KKKatarzyna Koper
Katarzyna Koper
KBKatarzyna Brzeźniakiewicz-Janus
Katarzyna Brzeźniakiewicz-Janus
Bone marrow studies currently provide a lot of valuable information in the diagnostics of hematological diseases including hematopoietic stem cells disorders. Our studies on low-molecular weight organic compounds in bone marrow stem cell niche in various pathogenic conditions, revealed relatively high variability of histamine levels in different groups of hematological diseases. It was also found that serotonin levels were significantly lower than those typically measured in peripheral blood as well as many have the influence on stem cells proliferative potential. This paper presents findings from quantitative and statistical analyses of histamine and serotonin levels. Bone marrow collected from patients undergoing routine diagnostic procedures for hematological diseases and receiving inpatient treatment were analyzed. Histamine and serotonin levels were measured using hydrophilic interaction liquid chromatography (HILIC) coupled with tandem mass spectrometry. Obtained data were analyzed statistically and correlated with the diagnosed groups of hematological diseases and the parameters of complete blood counts. Histamine was found in all tested samples, including those from patients without malignancy, and the reported levels were comparable to the reference values in blood. This observation allows us to assume that bone marrow cells can produce and accumulate histamine. Moreover, the statistical analysis revealed a significant relationship between histamine levels and diagnosed mastocytosis, and between histamine levels and myeloproliferative neoplasms. Different results were obtained for serotonin, and its concentrations in most cases were below the limit of quantification of the method used (< 0.2 ng/mL), which can only be compared to peripheral blood plasma. In a few cases, significantly higher serotonin levels were observed and it concerned diseases associated with an increased number of megakaryocytes in the bone marrow.

1 June 2020 in Pomeranian Journal of Life Sciences
Verified
Journal Article
Open access
PDF file
BPBarbara Potocka-Banaś
Barbara Potocka-Banaś
USUrszula Semeniuk
Urszula Semeniuk
SMSlawomir Majdanik
Slawomir Majdanik
KBKrzysztof Borowiak
Krzysztof Borowiak
TJTomasz Janus
Tomasz Janus
Introduction: Intoxication with new psychoactive substances (NPSs), colloquially known as designer drugs, has become a significant problem in the last several years. The aim of the study was to conduct a statistical analysis of retrospective data from test records for the presence of NPSs in patients hospitalized in 2015–2018 in the West Pomeranian province. Materials and methods: We analyzed 5,916 results of tests undertaken at the Department of Clinical and Forensic Toxicology at Pomeranian Medical University in Szczecin. Blood samples had been analyzed by liquid chromatography coupled with mass spectrometry (LC/MS) and Headspace gas chromatography (GC/Headspace). Results: Our research was based on 5,916 diagnostic tests for poisoning with volatile and non-volatile organic compounds carried out in 2015–2018 at Pomeranian Medical University in Szczecin. Psychoactive substances used for non-medical purposes were detected in 1,465 patients. In the period under analysis 1,328 of these patients were poisoned with classic psychoactive substances, the poisonings caused by the intentional use NPS were recorded in 137. Conclusions: A retrospective analysis of the above-mentioned data for the period 2015–2018 revealed a gradual increase in the incidence of poisoning with psychoactive substances used for non-medical purposes. Keywords: intoxication; new psychoactive substances; designer drugs; data analysis; diagnostic tests.

2 November 2023 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
BBBarbara Potocka Banaś
Barbara Potocka Banaś
KBKatarzyna Brzeźniakiewicz‐Janus
Katarzyna Brzeźniakiewicz‐Janus
SMSlawomir Majdanik
Slawomir Majdanik
MPMirosław Parafiniuk
Mirosław Parafiniuk
SŁSylwester Łużny
Sylwester Łużny
TJTomasz Janus
Tomasz Janus